May 28 (Reuters) - Paradigm Biopharmaceuticals Ltd PAR.AX :
* PARADIGM REPORTS GREATER THAN 50% PAIN REDUCTION ACROSS 205 PATIENTS WITH KNEE OSTEOARTHRITIS
May 28 (Reuters) - Paradigm Biopharmaceuticals Ltd PAR.AX :
* PARADIGM REPORTS GREATER THAN 50% PAIN REDUCTION ACROSS 205 PATIENTS WITH KNEE OSTEOARTHRITIS